...
首页> 外文期刊>European review for medical and pharmacological sciences. >High sensitive C-reactive protein: a new marker for urinary tract infection, VUR and renal scar
【24h】

High sensitive C-reactive protein: a new marker for urinary tract infection, VUR and renal scar

机译:高敏C反应蛋白:尿道感染,VUR和肾疤痕的新标志物

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Accurate diagnosis and early treatment of urinary tract infections (UTS) are important because of its association with renal scarring (RS).AIMS: To investigate the serum levels of fl-bronectin, high sensitive CRP (Hs-CRP), urinary fibronectin, and beta-2 microgiobulin (beta2MG) levels in patients with UTI and relationship of these parameters with VUR (vesicoureteral reflex) and RS.PATIENTS AND METHODS: 72 patients were included in study and divided into three groups: Group I (20 patients with first UTS); Group II (16 patients with recurrent UTI with VUR); Group f!i (16 patients without UTI with VUR).RESULTS: Serum and urine fibronectin levels were similar in all study groups and controls. Urinary beta2MG levels were higher in Group I! (302±179 ng/ml) than in the Group I (134±90 ng/ml) (p < 0.001). Moreover, beta2WIG levels were similar in Group El (302+179 ng/ml) and group HI (218+147 ng/ml). By contrast, beta2MG levels were higher in Group III (218+147 ng/ml) than in the controls (64+32 ng/ml) (p < 0.001). Hs-CRP levels were higher in Group I (1.8+2.7 mg/L), Group I! (23.1 ±32 mg/L), and II! (0.4±0.1 mg/L) than the controls (0.2+0.08 mg/L) (p < 0.001). Hs-CRP levels were higher in Group I! (23.1+31.9 mg/L) than in the Group I (1.8+2.7 mg/L) (p < 0.001). Hs-CRP levels were higher in Group I (1.8+2.7 mg/L) and Group I! (23.1+31.9 mg/L) than in the Group HI (0.4+0.1 mg/L) (p < 0.001). Hs-CRP levels were higher in group HI (0.37±0.17 mg/L) than in the controls (0.2±0.08 mg/L) (p < 0.001). Hs-CRP (18.8+25 mg/L) and beta2MG levels (349.4+128.5 ng/ml) were different in UTI with RS from the controls (0.2+0.08 mg/L and 64±32 ng/ml respectively, p < 0.001). Fibronectin levels were similar in patients with and without RS.CONCLUSIONS: Increased urinary beta2MG and Hs-CRP were observed in initial UTi and recurrent UTI with VUR, Fibronectin levels were not useful for detection of first and recurrent UTI with VUR and RS. Elevated Hs-CRP levels can help us predetermine the patients with VUR prone to proceed to clinical chronic renal failure.
机译:背景:尿路感染(UTS)与肾脏瘢痕形成(RS)相关,因此准确诊断和早期治疗很重要。目的:研究血清纤连蛋白,高敏CRP(Hs-CRP)和尿纤连蛋白的水平,UTI患者的β2微血管球蛋白(beta2MG)水平以及这些参数与VUR(膀胱输尿管反射)和RS的关系。患者与方法:研究纳入72例患者,分为三组:第一组(20例患者第一个UTS);第二组(16例UTI合并VUR复发);结果:在所有研究组和对照组中,血清和尿中纤连蛋白水平相似。第一组的尿中beta2MG水平更高! (302±179 ng / ml)比第一组(134±90 ng / ml)(p <0.001)。而且,在E1组(302 + 179 ng / ml)和HI组(218 + 147 ng / ml)中,β2WIG水平相似。相比之下,III组(218 + 147 ng / ml)中的beta2MG水平高于对照组(64 + 32 ng / ml)(p <0.001)。 I组Hs-CRP水平较高(1.8 + 2.7 mg / L)! (23.1±32 mg / L)和II! (0.4±0.1 mg / L)比对照(0.2 + 0.08 mg / L)(p <0.001)。第一组中的Hs-CRP水平更高! (23.1 + 31.9 mg / L)高于第一组(1.8 + 2.7 mg / L)(p <0.001)。第一组和第一组的Hs-CRP水平较高(1.8 + 2.7 mg / L)! (23.1 + 31.9 mg / L)高于HI组(0.4 + 0.1 mg / L)(p <0.001)。 HI组的Hs-CRP水平(0.37±0.17 mg / L)高于对照组(0.2±0.08 mg / L)(p <0.001)。带有RS的UTI患者的Hs-CRP(18.8 + 25 mg / L)和beta2MG水平(349.4 + 128.5 ng / ml)与对照组相比分别为0.2 + 0.08 mg / L和64±32 ng / ml,p <0.001 )。结论:在初次UTi和复发性UTI合并VUR的患者中,尿β2MG和Hs-CRP升高,而未结合RS的患者纤连蛋白水平升高。升高的Hs-CRP水平可以帮助我们预先确定易发生VUR的患者进行临床慢性肾功能衰竭。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号